Drug: EMEND Injury: Malignant neoplasm progression Quarter: 2016Q3
Total Records: 2 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
126159353 | EMEND | Malignant neoplasm progression | MERCK | 66.00 YR | F | 0 | 20160909 | US |
126212372 | EMEND | Malignant neoplasm progression | MERCK | 70.42 YR | M | 0 | 20160920 | US |
Total Records: 2 Number of Pages: 1